CIRSE Registry for LifePearl Microspheres
NCT: NCT03086096 · COMPLETED
Brief Summary
The application of transarterial chemoembolisation (TACE) using LifePearl Microspheres loaded with Irinotecan in liver-only or liver-dominant metastatic disease in patients with colorectal adenocarcinoma will be observed. The registry has the following objectives: 1. map the exact indications that the device is being used for and at which stage in treatment it is being applied 2. to assess observed treatment outcomes in terms of safety and effectiveness as well as trying to determine any predictive response factors
Frequently Asked Questions
What is CIRSE Registry for LifePearl Microspheres?
CIRSE Registry for LifePearl Microspheres is a clinical trial registered under NCT03086096. Current status: COMPLETED.
What is the status of NCT03086096?
The current status of NCT03086096 (CIRSE Registry for LifePearl Microspheres) is: COMPLETED.
When did CIRSE Registry for LifePearl Microspheres start?
CIRSE Registry for LifePearl Microspheres started on 2018-02-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.